期刊文献+

胸腺瘤组织学分型与重症肌无力及临床分期关系 被引量:7

Study on the relationship of the histologic classification of thymoma to myasthe nia gravis and clinical stages
下载PDF
导出
摘要 目的:探讨胸腺瘤最新WHO病理分型与重症肌无力(MG)及临床分期之间的关系.方法:回顾分析1980~2004年间74例因胸腺瘤行胸腺切除的患者,运用最新WHO分型标准(1999)对胸腺瘤进行重新分类,并运用统计软件对新的WHO组织学分型与MG的发生率及Masaoka临床分期之间的关系做进一步分析.结果:①胸腺瘤A型2例,AB型23例,B1型4例,B2型27例,B3型16例,C型2例.其中B2型较AB、B1及B3型易合并MG(P<0.05),A型两例均合并MG,而C型则均未合并MG.②临床Ⅰ期:1例,Ⅱ期:30例,Ⅲ期:38例,Ⅳ期:5例.新的WHO组织学分型与Masaoka分期之间关系密切(P<0.01).结论:新WHO组织学分型与胸腺瘤合并MG的发生率之间有一定关系,同时能反映其临床分期及评价患者的预后. Purpose:To investigate the relationship of the latest WHO classification of thymic epithelial tumors(TET) to myasthenia gravis( MG) and clinical stages. Methods:The pathological sections of 74 patients with thymoma f rom 1980~2004 using WHO classification(1999) were reviewed,statistical softwar e was used to analyse the relationship of the WHO classification to MG and clini cal stages. Results:①Two cases of type A, 23 cases of type AB, 4 cases of type B 1 ,27 cases of type B 2 , 16 cases of type B 3 and 2 cases o f type C were classified. Type B 2 is more likely to be accompanied by MG( P<0.05), while no MG occurred for type C.②One patient was in stage Ⅰ,30 we re in stageⅡ,38 were in stage Ⅲ, 5 were in stage Ⅳ. The latest histologic cla ssification significantly correlated with Masaoka stages (P<0.01). Conclusions:The latest WHO classification correlated with occur rence of MG and clinical stages , it can also evaluate the prognosis of patients .
出处 《中国癌症杂志》 CAS CSCD 2005年第1期55-56,60,共3页 China Oncology
关键词 胸腺瘤 重症肌无力 临床分期 thymoma myasthenia gravis clinical stages
  • 相关文献

参考文献11

  • 1薛志强,王如文,蒋耀光,谭群友,赵云平.胸腺瘤患者预后因素分析[J].中国胸心血管外科临床杂志,2003,10(2):98-100. 被引量:13
  • 2郭秀海,吴卫平.家族性正常血钾性周期性麻痹一家系18例报告[J].临床神经病学杂志,2002,15(1):35-35. 被引量:3
  • 3Harris NL, Müler-Hermelink HK,Thymoma classification :a siren's song of simplicity [ J ]. Am J Clin Pathol, 1999, 112 ( 3 ): 299-303.
  • 4Suster S, Moran CA, Thymona classification. The ride of the Valkyries[ J]. Am J Clin Pathol, 1999,112( 3 ) :308-310.
  • 5Marx A, Müller-Hermelink HK. From basic immunobiology to the upcoming WHO-classification of tumors of the thymus. The Second Conference on Biological and Clinical Aspects of Thymic Epithelial Tumors and related recent developments [ J ]. Pathol Res Pract, 1999,195(8) :515-533.
  • 6Müller-Hermelink HK, Marx A. Pathological aspects of malignant and benign thymic disorders[ J]. Ann Med, 1999,31( Suppl 2) :5.
  • 7Okumura M, Miyoshi S, Fajii Y, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasmas: a study of 146 consecutive tumor[J]. Am J Surg Pathol, 2001,25( 1 ): 103-110.
  • 8Nakamura H, Taniguchi Y, Ohgi S. Clinicopathological character and long term results of thymic epithelial tumor categorized by WHO classification[J]. Kyobu Geka, 2002,55(11): 931-935.
  • 9Kirchner T, Tzartos S, Hoppe F, et al. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors [ J ]. Am J Pathol, 1988,130(2) :268-280.
  • 10Wilisch A, Gutsche S, Hoffacker V, et al. Association of AchR αsubunit gene expression in mixed thymoma with myasthenia gravis [ J ]. Neurology, 1999,52 ( 7 ): 1460-1466.

二级参考文献13

  • 1刘庆波.正常血钾性周期麻痹一家系报告[J].中国神经免疫学和神经病学杂志,1999,6:217-217.
  • 2Morgenthaler TI,Brown LR,Colby TV,et a1.Thymoma.Mayo Clin Proc,1993,68(11):1110—1123.
  • 3Marx A,Muller—Hermelink HK.From basic immunobiology to the upcoming WHO—classification of tumors of the thymus.The Second Conference on Biological and Clinical Aspects of Thymic Epithelial Tumors and related recent developments.Pathol Res Pract,1999,195(8):515-533.
  • 4Gripp S,Hilgers K,Wurm R,et a1.Thymoma:prognostic factors and treatment outcomes.Cancer,1 998,83(8):1 495-1503.
  • 5Lee WS,Heo DS,Bang YJ,et a1.Prognostic factors of patients with thymoma.Korean J Intern Med,1996,11(1):40—49.
  • 6Batata MA, Martini N,Huvos AG,Thymomas:clinicopathologic features,therapy,and prognosis.Cancer,1974,34(2):389—396.
  • 7Maggi G,Casadio C,Cavallo A,et a1.Thymoma:results of 241 operated cases.Ann Thorac Surg,1991,51(1):152—156.
  • 8Moreno Egea A,Aguayo Albasini JL,Parrilla Payicio P,et al.Prognostic factors of thymomas.Eur J Surg Oncol,1995,21(5):482—485.
  • 9Masaoka A,Monden Y,Nakahara K,et a1.Follow—up study of thymomas with special reference to their clinical stages.Cancer.1981,48(11):2485-2492.
  • 10Murakawa T,Nakajima J,Kohno T,et al.Results from surgical treatment for thymoma 43 years of experience.Jpn J Thorac Cardiovasc Surg,2000,48(2):89—95.

共引文献14

同被引文献67

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部